Language
en 
    My Cart  

    Renu Voice / Renu Gel

    RENU: The Power of Voice
    Renu_Voice_Logo

    Calcium Hydroxylapatite (CaHA)

    for long term management of vocal fold insufficiency

    RENU Voice
    RENU_gel_logo

    Sodium Carboxymethylcellulose (Na-CMC)

    for short term management of vocal fold insufficiency

    RENU Gel

    The choice for long- or short-term augmentation

    RENÚ Voice is for long-term augmentation:

    • A buffered hydrogel with synthetic, proven-biocompatible calcium hydroxylapatite (CaHA) particles 25 to 45 microns in size for consistent and easy injection.1



    RENÚ Gel is for short-term augmentation:

    • A buffered hydrogel of sodium carboxymethylcellulose2 (Na-CMC) and glycerin.
    • Resorbs slowly in vivo, providing a scaffold for local tissue infiltration.3



    Higher volume, less waste

    Both RENÚ Voice and RENÚ Gel provide a greater volume of material than competitive products: 1.5 cc vs. 1.0 cc.1 The greater volume:

    • Helps eliminate waste and inconvenience.
    • Reduces the added cost of opening additional syringes.

    Convenience and comfort at your fingertips

    Both RENÚ Voice and RENÚ Gel are provided in sterile, ready-to-use 1.5 cc syringes with ergonomic finger grips and 2-year shelf life.

    Inject RENÚ Voice or RENÚ Gel percutaneously with a needle of your choice or with the RENÚ Double-Bevel, Transoral Needle, supplied separately.3,4

    Side view of larynx

    INJECTION OPTIONS:

    Operating Room (OR) Trans-Oral Injection

    • Visualization via direct laryngoscopy or micro-laryngoscopy
    Operating Room Trans-Oral Injections

    Operating Room Trans-Oral Injections

    Office Based Trans-Oral Injection

    • Topical anesthesia
    • Attach appropriate needle to RENÚ
    • Prime needle with RENÚ (dead volume equals ≈0.28cc)
    Calcium Hydroxylapatite (CaHA)

    Calcium Hydroxylapatite (CaHA)

    Office Based Percutaneous Injections

    Cricothyroid Cartilage Approach

    Cricothyroid Cartilage Approach

    Thyroid Cartilage Approach

    Thyroid Cartilage Approach

    Thyroid Approach

    Thyroid Approach

    RENU Voice is FDA-cleared and CE-marked for injectable VFI augmentation applications.

    RENU Gel is FDA-cleared for injectable VFI augmentation applications.¹

    REFDescriptionRx
    08-015-00-V04RENÚ Gel Hydrogel Implant, 1.5cc •
    08-015-04-V04RENÚ Voice Calcium Hydroxylapatite Implant, 1.5cc•
    08-015-04-VOIRENÚ Voice Calcium Hydroxylapatite Implant, 1.5cc, CE•
    12-000-00-ND1RENÚ Transoral Needle, 24 gauge needle tip, 9.8 inches long, 16 gauge shaft•

    These products are restricted to sale or use by a licensed professional only.

    Billing CodeDescriptionRx
    31570Direct laryngoscopy with injection (office and OR)•
    31571Microlaryngoscopy with injection ( OR only) (microscopic or telescopic)•
    31574Laryngoscopy, flexible; with injection(s) for augmentation•
    31575Laryngoscopy, flexible; diagnostic•
    31579Laryngoscopy, flexible or rigid telescopic, with stroboscopy•
    31599Flexible laryngoscopy with injection (trans-oral or percutaneous)•
    L8607Injectable bulking agent for vocal cord medialization, 0.1 cc•

    Source: FindACode.com 12.3.19

    Support from a trusted global leader

    RENÚ Voice and RENÚ Gel are backed with comprehensive support from InHealth Technologies, a global leader.

    To order RENÚ Voice and RENÚ Gel, visit https://inhealth.com/products/ent-products/renur.html

    References:
    1. Data on file, InHealth Technologies.
    2. Mallur PS, et al. Safety and efficacy of carboxymethylcellulose in the treatment of glottic insufficiency. The Laryngoscope. 2012;122:322–326. https://doi.org/10.1002/lary.21930.
    3. Hughes RGM, Morrison M. Vocal cord medialization by transcutaneous injection of calcium hydroxylapatite. Journal of Voice. 2005;19(4):674-678.
    4. Carroll TL, Rosen CA. Long-term results of calcium hydroxylapatite for vocal fold augmentation. The Laryngoscope. 2011;121:313–319.